GENE ONLINE|News &
Opinion
Blog

Huntington's Disease
Human Skin Cells Reprogramming Creates New Neurodegenerative Model For Huntington’s Disease
2022-08-31
The FDA Granted These Three Companies Orphan Drug Designations in One Day
2022-05-13
Wave Initiates Trial of Investigational Antisense Oligonucleotide Against Huntington’s Disease
2021-09-13
Vaccinex’s Drug Flounders Huntington’s Trial, but Shows Promise against Another Neurodegenerative Disease
2020-09-24
R&D
Altering the Treatment Landscape of Neurodegenerative Diseases Using Antisense Oligonucleotides (ASOs)
2020-08-17
Spotlight: New Gene Therapies on the Horizon for the Treatment of Neurogenetic Diseases
2020-08-03
Small molecule Fights Huntington Disease By Diminishing Vicious CAG Triplet Repeats
2020-02-24
LATEST
Healthcare+ Expo Taiwan 2024 To Become A Global Trade Fair With 600+ Companies Attending
2024-11-29
Cracking the Code: How Genetics Shapes Strength, Power, and Speed in Sports
2024-11-27
Shared Expertise, Shared Vision: Biotech Powerhouses Drive Innovation in This Billion-Dollar Market
2024-11-27
MIRDC Hosts Seminar Featuring Diverse Applications of Plasma Sterilization Technology
2024-11-26
How Minaris is Tackling the Scalability Challenge in Cell and Gene Therapy: A Conversation with CEO, Dr. Hiroto Bando
2024-11-26
PuriBlood Breaks into Brazil: Partners with ABHH and Cromo to Conquer Latin America’s Largest Blood Market
2024-11-26
Merck’s Multi-Billion-Dollar KEYTRUDA Levels Up with Novel Subcutaneous Delivery, Matching IV Efficacy
2024-11-22
EVENT
2024-12-05
8th Healthcare Expo Taiwan
Taipei, Taiwan
Scroll to Top